Senior/Principal Scientist, Oligonucleotide Discovery (siRNA/ASO)
Company: GondolaBio Service Co, Inc.
Location: Palo Alto
Posted on: February 18, 2026
|
|
|
Job Description:
Job Description Job Description Description: Senior / Principal
Scientist, Oligonucleotide Discovery (siRNA / ASO) Palo Alto, CA or
Shanghai, China About GondolaBio GondolaBio is a clinical-stage
biopharmaceutical company focused on developing breakthrough
therapeutics for genetic diseases. GondolaBio is an independent
sister company to BridgeBio, originally carved out in 2024 after
securing $300M in private financing from external investors.
GondolaBio aims to leverage cutting-edge biological research to
discover, create, test, and deliver transformative medicines to
treat patients who suffer from genetic diseases. Who You Are You
are a seasoned industry scientist in oligonucleotide therapeutics,
with deep hands-on experience in siRNA and/or antisense
oligonucleotide (ASO) discovery and early development. You have
direct experience supporting one or more IND submissions,
contributing preclinical, DMPK, and/or safety packages that enabled
program advancement into the clinic. You bring strong scientific
judgment and thrive in a collaborative, fast-paced biotech
environment. You operate as a technical leader and subject-matter
expert, capable of critically evaluating oligo design strategies,
assay approaches, and complex preclinical datasets. You work
effectively with cross-functional partners and are able to
influence program direction through rigorous, data-driven
scientific insight, particularly in the context of IND-enabling
decision-making. Key Responsibilities Preclinical Safety &
Off-Target Risk Analysis Lead the integration and interpretation of
preclinical safety and pharmacology data , with a strong focus on
off-target effects to inform program decisions. Partner closely
with toxicology and biology teams to distinguish target-related
versus off-target findings , assess dose-limiting toxicities, and
evaluate overall therapeutic index and risk profile. Identify data
gaps, recommend mechanistic or follow-up studies, and support risk
mitigation strategies based on preclinical safety findings. CRO &
External Partner Oversight Provide scientific oversight of
CRO-executed studies , including preclinical safety, in vivo
pharmacology, and supporting studies relevant to oligonucleotide
programs. Review and provide input on study designs, protocols,
data packages, and final reports to ensure scientific rigor,
relevance, and alignment with program objectives. Serve as a
primary scientific point of contact with external partners to
ensure clear communication, high-quality execution, and timely
delivery. Oligonucleotide DMPK & PK/PD Integration Contribute to
scientific evaluation of oligonucleotide DMPK data , including
pharmacokinetics, biodistribution, tissue uptake, and durability of
effect. Collaborate closely with DMPK teams to assess
exposure–response and PK/PD relationships , and to contextualize
safety findings relative to systemic and tissue-level exposure.
Integrate DMPK insights into cohesive preclinical and translational
narratives that support candidate selection and development
planning. Cross-Functional Collaboration & Decision Support
Collaborate closely with chemistry, DMPK, toxicology,
translational, and clinical teams to support data-driven program
decisions. Clearly summarize and communicate complex preclinical
datasets in team meetings and governance forums. Oligonucleotide
Program Support & Scientific Oversight Serve as a senior scientific
contributor to siRNA and/or ASO programs , providing expert
understanding of oligonucleotide design strategies, chemistry, and
biology without direct hands-on design or assay development
responsibilities. Critically review and contextualize oligo design,
modification strategies, and conjugation approaches proposed by
internal teams and external partners. Preferred Education &
Experience Ph.D. in molecular biology, pharmacology, chemistry, or
a related field, or equivalent advanced degree. 8 years of industry
experience in oligonucleotide drug discovery and/or development
(siRNA and/or ASO strongly preferred). Demonstrated hands-on
experience in oligo design, assay development, and in vitro/in vivo
pharmacology. Prior experience contributing to programs advancing
toward IND. Familiarity with oligonucleotide DMPK concepts,
including PK/PD and biodistribution. Experience managing and
collaborating with external CROs. Strong data analysis,
presentation, and scientific communication skills. Nice-to-Haves
Exposure to conjugated oligos (e.g., GalNAc or other ligand-based
approaches). Experience supporting translational or
biomarker-related studies. Experience across both siRNA and ASO
modalities. Chinese Mandarin language proficiency (spoken and/or
written) is a plus. Prior experience in a small or fast-growing
biotech environment. No matter your role at GondolaBio, successful
team members are Patient Champions, who put patients first and
uphold strict ethical standards. Entrepreneurial Operators, who
drive toward practical solutions and have an ownership mindset.
Truth Seekers, who are detailed, rational, and humble problem
solvers. Individuals Who Inspire Excellence in themselves and those
around them. High-quality executors, who execute against goals and
milestones with quality, precision, and speed. What We Offer
Patient Days, where we are fortunate to hear directly from
individuals living with the conditions we are seeking to impact
throughout the year and learn how we can improve our efforts. A
culture inspired by our values: put patients first, think
independently, be radically transparent, every minute counts, and
let the science speak. An unyielding commitment to always putting
patients first. A de-centralized model that enables our program
teams to focus on advancing science and helping patients. Our
affiliate structure is designed to eliminate bureaucracy and put
decision-making power in the hands of those closest to the science.
A place where you own the vision – both for your program and your
own career path. A collaborative, fast-paced, data-driven
environment where we inspire ourselves and each other to always
perform at the top of our game. Access to learning and development
resources to help you get in the best professional shape of your
life. Robust and market-competitive compensation & benefits package
(Base, Performance Bonus, Equity, health, welfare & retirement
programs). Flexible PTO. Rapid career advancement for strong
performers. Potential ability to work on multiple GondolaBio Pharma
programs across multiple therapeutic areas over time. Partnerships
with leading institutions. Commitment to Diversity, Equity &
Inclusion. The base pay range for this position for the United
States is $185,000 to $215,000 per year. The actual compensation
offered will be determined based on a number of job-related
factors, including experience, skills, qualifications, and
location. A bonus plan and equity will also be offered.
Requirements:
Keywords: GondolaBio Service Co, Inc., Danville , Senior/Principal Scientist, Oligonucleotide Discovery (siRNA/ASO), Science, Research & Development , Palo Alto, California